A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases

S Batra, S Jahan, A Ashraf, B Alharby, T Jawaid… - International Journal of …, 2023 - Elsevier
Abstract Cyclin-dependent kinase 5 (CDK5) is the serine/threonine-directed kinase mainly
found in the brain and plays a significant role in developing the central nervous system …

Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease

AS Bhounsule, LK Bhatt, KS Prabhavalkar, M Oza - Brain research bulletin, 2017 - Elsevier
Alzheimer's disease (AD) is one of the most frequently encountered diseases in adults with
progressive loss of memory and behavioral changes. Inspite of there being an intense …

Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target

V Krystof, S Baumli, R Furst - Current pharmaceutical design, 2012 - ingentaconnect.com
Deregulation of cyclin-dependent kinases (CDKs) has been associated with many cancer
types and has evoked an interest in chemical inhibitors with possible therapeutic benefit …

A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)

M Kovalová, JP Baraka, V Mik, R Jorda… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Cyclin-dependent kinase 7 (CDK7) is a member of the CDK family of
serine/threonine protein kinases and participates in the regulation of the cell cycle and …

Physiological and pathological roles of Cdk5: potential directions for therapeutic targeting in neurodegenerative disease

AB Allnutt, AK Waters, S Kesari… - ACS chemical …, 2020 - ACS Publications
Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine (ser)/threonine (Thr) kinase
that has been demonstrated to be one of the most functionally diverse kinases within …

Cyclin-dependent kinase 5 (Cdk5): a potential therapeutic target for the treatment of neurodegenerative diseases and diabetes mellitus

FY Wei, K Tomizawa - Mini Reviews in Medicinal Chemistry, 2007 - ingentaconnect.com
Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine protein kinase, which forms active
complexes with p35 or p39 expressed predominantly in neurons. Cdk5 is indispensable for …

Design and synthesis of quinolin-2 (1H)-one derivatives as potent CDK5 inhibitors

W Zhong, H Liu, MR Kaller, C Henley, E Magal… - Bioorganic & medicinal …, 2007 - Elsevier
Cyclin-dependent kinase 5 (CDK5) is a serine/threonine protein kinase and its deregulation
is implicated in a number of neurodegenerative disorders such as Alzheimer's disease …

[HTML][HTML] The role of Cdk5 in neurological disorders

C Ao, C Li, J Chen, J Tan, L Zeng - Frontiers in cellular neuroscience, 2022 - frontiersin.org
Neurological disorders are a group of disorders with motor, sensory or cognitive damage,
caused by dysfunction of the central or peripheral nervous system. Cyclin-dependent …

[HTML][HTML] Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders

Z Tian, B Feng, XQ Wang, J Tian - Frontiers in Molecular …, 2022 - frontiersin.org
Cyclin-dependent kinases 5 (Cdk5) is a special member of proline-directed serine threonine
kinase family. Unlike other Cdks, Cdk5 is not directly involved in cell cycle regulation but …

CDK5 in oncology: recent advances and future prospects

JL Lenjisa, S Tadesse, NZ Khair… - Future medicinal …, 2017 - Future Science
Selective abrogation of cyclin-dependent kinases (CDK) activity is a highly promising
strategy in cancer treatment. The atypical CDK, CDK5 has long been known for its role in …